Last reviewed · How we verify

NCT04129333: HYPIC

HYPIC Hypnosis for Procedural Pain in the Intensive Care Unit

Completed NA Last updated 9 November 2022
What this trial tests

NA trial testing Hypnosis in Invasive Procedure in 80 participants. Completed in 11 October 2022.

Timeline
30 December 2019
Primary endpoint
25 January 2022
11 October 2022

Quick facts

Lead sponsorRennes University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment80
Start date30 December 2019
Primary completion25 January 2022
Estimated completion11 October 2022
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Rennes University Hospital

Who can join

18 and older, any sex, with Invasive Procedure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Procedural pain in resuscitation is common in the conscious patient. However, analgesia and sedation may be impossible because of the acute pathology leading to resuscitation, comorbidities or the urgency of the invasive procedure. In addition, the use of analgesics and sedatives is responsible for adverse effects. In this context, hypnosis appears to be an additional analgesic tool that would reduce the consumption of analgesics and sedatives and thus reduce their side effects.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Hypnosis for unplanned procedural pain in the intensive care unit: the HYPIC randomized clinical trial.
    Maamar A, Faleur C, Pedrono K, Adeux MP, et al · · 2025 · PMID 40682163 · DOI 10.1186/s13054-025-05563-9

Verify or expand the search:

Other trials of Hypnosis

Trials testing the same drug.

Other Rennes University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04129333.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing